Migdal Insurance & Financial Holdings’s Nurix Therapeutics NRIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-371	Closed	-$11K	–	664
2021 Q4	$11K	Sell	371 -224	-38%	-$6.64K	﹤0.01%	590
2021 Q3	$18K	Buy	+595	New	+$18K	﹤0.01%	562